Obtaining Prevalence Estimates of Coronavirus Disease 2019: A Model to Inform Decision-Making.

We evaluated whether randomly sampling and testing a set number of individuals for coronavirus disease 2019 (COVID-19) while adjusting for misclassification error captures the true prevalence. We also quantified the impact of misclassification error bias on publicly reported case data in Maryland. Using a stratified random sampling approach, 50,000 individuals were selected from a simulated Maryland population to estimate the prevalence of COVID-19. We examined the situation when the true prevalence is low (0.07%-2%), medium (2%-5%), and high (6%-10%). Bayesian models informed by published validity estimates were used to account for misclassification error when estimating COVID-19 prevalence. Adjustment for misclassification error captured the true prevalence 100% of the time, irrespective of the true prevalence level. When adjustment for misclassification error was not done, the results highly varied depending on the population's underlying true prevalence and the type of diagnostic test used. Generally, the prevalence estimates without adjustment for misclassification error worsened as the true prevalence level increased. Adjustment for misclassification error for publicly reported Maryland data led to a minimal but not significant increase in the estimated average daily cases. Random sampling and testing of COVID-19 are needed with adjustment for misclassification error to improve COVID-19 prevalence estimates.

A Particle-Based COVID-19 Simulator With Contact Tracing and Testing.

Goal: The COVID-19 pandemic has emerged as the most severe public health crisis in over a century. As of January 2021, there are more than 100 million cases and 2.1 million deaths. For informed decision making, reliable statistical data and capable simulation tools are needed. Our goal is to develop an epidemic simulator that can model the effects of random population testing and contact tracing. Methods: Our simulator models individuals as particles with the position, velocity, and epidemic status states on a 2D map and runs an SEIR epidemic model with contact tracing and testing modules. The simulator is available on GitHub under the MIT license. Results: The results show that the synergistic use of contact tracing and massive testing is effective in suppressing the epidemic (the number of deaths was reduced by 72%). Conclusions: The Particle-based COVID-19 simulator enables the modeling of intervention measures, random testing, and contact tracing, for epidemic mitigation and suppression.